Bill Text: TX HB3262 | 2013-2014 | 83rd Legislature | Comm Sub
Bill Title: Relating to pharmacy benefit managers contracting with the child health plan program, the Medicaid managed care program, and health plans for certain government employees.
Sponsorship: Partisan Bill (Republican 1)
Status: (Introduced - Dead) 2013-05-04 - Committee report sent to Calendars [HB3262 Detail]
Download: Texas-2013-HB3262-Comm_Sub.html
| 83R24982 PMO-D | |||
| By: Miller of Comal | H.B. No. 3262 | ||
| Substitute the following for H.B. No. 3262: | |||
| By: Sheffield of Coryell | C.S.H.B. No. 3262 | ||
|
|
||
|
|
||
| relating to pharmacy benefit managers contracting with the child | ||
| health plan program, the Medicaid managed care program, and health | ||
| plans for certain government employees. | ||
| BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | ||
| SECTION 1. Chapter 531, Government Code, is amended by | ||
| adding Subchapter Y to read as follows: | ||
| SUBCHAPTER Y. PHARMACY BENEFIT MANAGERS | ||
| Sec. 531.990. APPLICABILITY. This subchapter applies only | ||
| to a Medicaid managed care program under Chapter 533 and the child | ||
| health plan program. | ||
| Sec. 531.991. TRANSPARENCY IN PHARMACY BENEFIT MANAGEMENT. | ||
| (a) In this section, "maximum allowable cost" means a maximum | ||
| reimbursement amount for a group of therapeutically and | ||
| pharmaceutically equivalent multiple source medications. | ||
| (b) Each contract to provide pharmacy benefit manager | ||
| services must require the pharmacy benefit manager to: | ||
| (1) establish: | ||
| (A) a method of calculating, updating, and | ||
| revising a maximum allowable cost for each covered medication; | ||
| (B) intervals not to exceed seven days for | ||
| updating or revising the maximum allowable cost for each medication | ||
| on the maximum allowable cost list; and | ||
| (C) for that contract a single maximum allowable | ||
| cost list that uniformly serves as a basis for the calculation of | ||
| reimbursement amounts for pharmacy claims covered by the child | ||
| health plan program or Medicaid managed care program; | ||
| (2) develop and maintain a public Internet website and | ||
| post and maintain on the website the information required by | ||
| Subdivision (1)(C); | ||
| (3) notify each retail pharmacy affected by a | ||
| modification of a maximum allowable cost of the modification on the | ||
| date of the modification; | ||
| (4) disclose the data sources from which the pharmacy | ||
| benefit manager obtains pricing data used in establishing a maximum | ||
| allowable cost; and | ||
| (5) not less frequently than once a week, notify each | ||
| retail pharmacy affected by the pharmacy benefit manager's | ||
| substitution or deletion of, or addition to, a data source from | ||
| which the pharmacy benefit manager obtains pricing data used in | ||
| establishing a maximum allowable cost of the substitution, | ||
| deletion, or addition. | ||
| (c) A contract to provide pharmacy benefit manager services | ||
| must require the pharmacy benefit manager to provide to the | ||
| commission the information described by Subsections (b)(1)(B) and | ||
| (C). On request, the commission shall provide the information to a | ||
| pharmacist or pharmacy. | ||
| (d) A contract to provide pharmacy benefit manager services | ||
| must require that each medication on a maximum allowable cost list: | ||
| (1) is listed as "A" or "B" rated in the most recent | ||
| version of the United States Food and Drug Administration's Drug | ||
| Products with Therapeutic Equivalence Evaluations, also known as | ||
| the Orange Book; | ||
| (2) is rated "NR" or "NA" by Medi-Span; or | ||
| (3) has a similar rating by a nationally recognized | ||
| reference. | ||
| (e) A contract to provide pharmacy benefit manager services | ||
| must require the pharmacy benefit manager to: | ||
| (1) provide a procedure for a retail pharmacy to | ||
| challenge a listed maximum allowable cost; | ||
| (2) respond to a challenge under that procedure not | ||
| later than the 15th day after the date the challenge is made; | ||
| (3) if the challenge is successful, adjust the maximum | ||
| allowable cost effective on the date the challenge is resolved and | ||
| apply the adjustment to all retail pharmacies under the contract; | ||
| (4) if the challenge is denied, provide each reason | ||
| for the denial; and | ||
| (5) report every 90 days to the commission the total | ||
| number of challenges made and denied in the preceding 90-day period | ||
| to the maximum allowable cost for each medication the maximum | ||
| allowable cost of which was challenged during that period. | ||
| SECTION 2. Subchapter B, Chapter 1551, Insurance Code, is | ||
| amended by adding Section 1551.0671 to read as follows: | ||
| Sec. 1551.0671. TRANSPARENCY IN PHARMACY BENEFIT | ||
| MANAGEMENT. (a) In this section, "maximum allowable cost" means a | ||
| maximum reimbursement amount for a group of therapeutically and | ||
| pharmaceutically equivalent multiple source medications. | ||
| (b) Each contract to provide pharmacy benefit manager | ||
| services must require the pharmacy benefit manager to: | ||
| (1) establish: | ||
| (A) a method of calculating, updating, and | ||
| revising a maximum allowable cost for each covered medication; | ||
| (B) intervals not to exceed seven days for | ||
| updating or revising the maximum allowable cost for each medication | ||
| on the maximum allowable cost list; and | ||
| (C) for that contract a single maximum allowable | ||
| cost list that uniformly serves as a basis for the calculation of | ||
| reimbursement amounts for pharmacy claims covered by the group | ||
| benefits program; | ||
| (2) develop and maintain a public Internet website and | ||
| post and maintain on the website the information required by | ||
| Subdivision (1)(C); | ||
| (3) notify each retail pharmacy affected by a | ||
| modification of a maximum allowable cost of the modification on the | ||
| date of the modification; | ||
| (4) disclose the data sources from which the pharmacy | ||
| benefit manager obtains pricing data used in establishing a maximum | ||
| allowable cost; and | ||
| (5) not less frequently than once a week, notify each | ||
| retail pharmacy affected by the pharmacy benefit manager's | ||
| substitution or deletion of, or addition to, a data source from | ||
| which the pharmacy benefit manager obtains pricing data used in | ||
| establishing a maximum allowable cost of the substitution, | ||
| deletion, or addition. | ||
| (c) A contract to provide pharmacy benefit manager services | ||
| must require the pharmacy benefit manager to provide to the board of | ||
| trustees the information described by Subsections (b)(1)(B) and | ||
| (C). On request, the board of trustees shall provide the | ||
| information to a pharmacist or pharmacy. | ||
| (d) A contract to provide pharmacy benefit manager services | ||
| must require that each medication on a maximum allowable cost list: | ||
| (1) is listed as "A" or "B" rated in the most recent | ||
| version of the United States Food and Drug Administration's Drug | ||
| Products with Therapeutic Equivalence Evaluations, also known as | ||
| the Orange Book; | ||
| (2) is rated "NR" or "NA" by Medi-Span; or | ||
| (3) has a similar rating by a nationally recognized | ||
| reference. | ||
| (e) A contract to provide pharmacy benefit manager services | ||
| must require the pharmacy benefit manager to: | ||
| (1) provide a procedure for a retail pharmacy to | ||
| challenge a listed maximum allowable cost; | ||
| (2) respond to a challenge under that procedure not | ||
| later than the 15th day after the date the challenge is made; | ||
| (3) if the challenge is successful, adjust the maximum | ||
| allowable cost effective on the date the challenge is resolved and | ||
| apply the adjustment to all retail pharmacies under the contract; | ||
| (4) if the challenge is denied, provide each reason | ||
| for the denial; and | ||
| (5) report every 90 days to the board of trustees the | ||
| total number of challenges made and denied in the preceding 90-day | ||
| period to the maximum allowable cost for each medication the | ||
| maximum allowable cost of which was challenged during that period. | ||
| SECTION 3. Subchapter C, Chapter 1575, Insurance Code, is | ||
| amended by adding Section 1575.111 to read as follows: | ||
| Sec. 1575.111. TRANSPARENCY IN PHARMACY BENEFIT | ||
| MANAGEMENT. (a) In this section, "maximum allowable cost" means a | ||
| maximum reimbursement amount for a group of therapeutically and | ||
| pharmaceutically equivalent multiple source medications. | ||
| (b) Each contract to provide pharmacy benefit manager | ||
| services must require the pharmacy benefit manager to: | ||
| (1) establish: | ||
| (A) a method of calculating, updating, and | ||
| revising a maximum allowable cost for each covered medication; | ||
| (B) intervals not to exceed seven days for | ||
| updating or revising the maximum allowable cost for each medication | ||
| on the maximum allowable cost list; and | ||
| (C) for that contract a single maximum allowable | ||
| cost list that uniformly serves as a basis for the calculation of | ||
| reimbursement amounts for pharmacy claims covered by the group | ||
| program; | ||
| (2) develop and maintain a public Internet website and | ||
| post and maintain on the website the information required by | ||
| Subdivision (1)(C); | ||
| (3) notify each retail pharmacy affected by a | ||
| modification of a maximum allowable cost of the modification on the | ||
| date of the modification; | ||
| (4) disclose the data sources from which the pharmacy | ||
| benefit manager obtains pricing data used in establishing a maximum | ||
| allowable cost; and | ||
| (5) not less frequently than once a week, notify each | ||
| retail pharmacy affected by the pharmacy benefit manager's | ||
| substitution or deletion of, or addition to, a data source from | ||
| which the pharmacy benefit manager obtains pricing data used in | ||
| establishing a maximum allowable cost of the substitution, | ||
| deletion, or addition. | ||
| (c) A contract to provide pharmacy benefit manager services | ||
| must require the pharmacy benefit manager to provide to the trustee | ||
| the information described by Subsections (b)(1)(B) and (C). On | ||
| request, the trustee shall provide the information to a pharmacist | ||
| or pharmacy. | ||
| (d) A contract to provide pharmacy benefit manager services | ||
| must require that each medication on a maximum allowable cost list: | ||
| (1) is listed as "A" or "B" rated in the most recent | ||
| version of the United States Food and Drug Administration's Drug | ||
| Products with Therapeutic Equivalence Evaluations, also known as | ||
| the Orange Book; | ||
| (2) is rated "NR" or "NA" by Medi-Span; or | ||
| (3) has a similar rating by a nationally recognized | ||
| reference. | ||
| (e) A contract to provide pharmacy benefit manager services | ||
| must require the pharmacy benefit manager to: | ||
| (1) provide a procedure for a retail pharmacy to | ||
| challenge a listed maximum allowable cost; | ||
| (2) respond to a challenge under that procedure not | ||
| later than the 15th day after the date the challenge is made; | ||
| (3) if the challenge is successful, adjust the maximum | ||
| allowable cost effective on the date the challenge is resolved and | ||
| apply the adjustment to all retail pharmacies under the contract; | ||
| (4) if the challenge is denied, provide each reason | ||
| for the denial; and | ||
| (5) report every 90 days to the trustee the total | ||
| number of challenges made and denied in the preceding 90-day period | ||
| to the maximum allowable cost for each medication the maximum | ||
| allowable cost of which was challenged during that period. | ||
| SECTION 4. Subchapter B, Chapter 1579, Insurance Code, is | ||
| amended by adding Section 1579.058 to read as follows: | ||
| Sec. 1579.058. TRANSPARENCY IN PHARMACY BENEFIT | ||
| MANAGEMENT. (a) In this section, "maximum allowable cost" means a | ||
| maximum reimbursement amount for a group of therapeutically and | ||
| pharmaceutically equivalent multiple source medications. | ||
| (b) Each contract to provide pharmacy benefit manager | ||
| services must require the pharmacy benefit manager to: | ||
| (1) establish: | ||
| (A) a method of calculating, updating, and | ||
| revising a maximum allowable cost for each covered medication; | ||
| (B) intervals not to exceed seven days for | ||
| updating or revising the maximum allowable cost for each medication | ||
| on the maximum allowable cost list; and | ||
| (C) for that contract a single maximum allowable | ||
| cost list that uniformly serves as a basis for the calculation of | ||
| reimbursement amounts for pharmacy claims covered by a health | ||
| coverage plan; | ||
| (2) develop and maintain a public Internet website and | ||
| post and maintain on the website the information required by | ||
| Subdivision (1)(C); | ||
| (3) notify each retail pharmacy affected by a | ||
| modification of a maximum allowable cost of the modification on the | ||
| date of the modification; | ||
| (4) disclose the data sources from which the pharmacy | ||
| benefit manager obtains pricing data used in establishing a maximum | ||
| allowable cost; and | ||
| (5) not less frequently than once a week, notify each | ||
| retail pharmacy affected by the pharmacy benefit manager's | ||
| substitution or deletion of, or addition to, a data source from | ||
| which the pharmacy benefit manager obtains pricing data used in | ||
| establishing a maximum allowable cost of the substitution, | ||
| deletion, or addition. | ||
| (c) A contract to provide pharmacy benefit manager services | ||
| must require the pharmacy benefit manager to provide to the trustee | ||
| the information described by Subsections (b)(1)(B) and (C). On | ||
| request, the trustee shall provide the information to a pharmacist | ||
| or pharmacy. | ||
| (d) A contract to provide pharmacy benefit manager services | ||
| must require that each medication on a maximum allowable cost list: | ||
| (1) is listed as "A" or "B" rated in the most recent | ||
| version of the United States Food and Drug Administration's Drug | ||
| Products with Therapeutic Equivalence Evaluations, also known as | ||
| the Orange Book; | ||
| (2) is rated "NR" or "NA" by Medi-Span; or | ||
| (3) has a similar rating by a nationally recognized | ||
| reference. | ||
| (e) A contract to provide pharmacy benefit manager services | ||
| must require the pharmacy benefit manager to: | ||
| (1) provide a procedure for a retail pharmacy to | ||
| challenge a listed maximum allowable cost; | ||
| (2) respond to a challenge under that procedure not | ||
| later than the 15th day after the date the challenge is made; | ||
| (3) if the challenge is successful, adjust the maximum | ||
| allowable cost effective on the date the challenge is resolved and | ||
| apply the adjustment to all retail pharmacies under the contract; | ||
| (4) if the challenge is denied, provide each reason | ||
| for the denial; and | ||
| (5) report every 90 days to the trustee the total | ||
| number of challenges made and denied in the preceding 90-day period | ||
| to the maximum allowable cost for each medication the maximum | ||
| allowable cost of which was challenged during that period. | ||
| SECTION 5. Subchapter B, Chapter 1601, Insurance Code, is | ||
| amended by adding Section 1601.065 to read as follows: | ||
| Sec. 1601.065. TRANSPARENCY IN PHARMACY BENEFIT | ||
| MANAGEMENT. (a) In this section, "maximum allowable cost" means a | ||
| maximum reimbursement amount for a group of therapeutically and | ||
| pharmaceutically equivalent multiple source medications. | ||
| (b) Each contract to provide pharmacy benefit manager | ||
| services must require the pharmacy benefit manager to: | ||
| (1) establish: | ||
| (A) a method of calculating, updating, and | ||
| revising a maximum allowable cost for each covered medication; | ||
| (B) intervals not to exceed seven days for | ||
| updating or revising the maximum allowable cost for each medication | ||
| on the maximum allowable cost list; and | ||
| (C) for that contract a single maximum allowable | ||
| cost list that uniformly serves as a basis for the calculation of | ||
| reimbursement amounts for pharmacy claims covered by the basic | ||
| coverage; | ||
| (2) develop and maintain a public Internet website and | ||
| post and maintain on the website the information required by | ||
| Subdivision (1)(C); | ||
| (3) notify each retail pharmacy affected by a | ||
| modification of a maximum allowable cost of the modification on the | ||
| date of the modification; | ||
| (4) disclose the data sources from which the pharmacy | ||
| benefit manager obtains pricing data used in establishing a maximum | ||
| allowable cost; and | ||
| (5) not less frequently than once a week, notify each | ||
| retail pharmacy affected by the pharmacy benefit manager's | ||
| substitution or deletion of, or addition to, a data source from | ||
| which the pharmacy benefit manager obtains pricing data used in | ||
| establishing a maximum allowable cost of the substitution, | ||
| deletion, or addition. | ||
| (c) A contract to provide pharmacy benefit manager services | ||
| must require the pharmacy benefit manager to provide to the | ||
| governing board of the system the information described by | ||
| Subsections (b)(1)(B) and (C). On request, the system shall | ||
| provide the information to a pharmacist or pharmacy. | ||
| (d) A contract to provide pharmacy benefit manager services | ||
| must require that each medication on a maximum allowable cost list: | ||
| (1) is listed as "A" or "B" rated in the most recent | ||
| version of the United States Food and Drug Administration's Drug | ||
| Products with Therapeutic Equivalence Evaluations, also known as | ||
| the Orange Book; | ||
| (2) is rated "NR" or "NA" by Medi-Span; or | ||
| (3) has a similar rating by a nationally recognized | ||
| reference. | ||
| (e) A contract to provide pharmacy benefit manager services | ||
| must require the pharmacy benefit manager to: | ||
| (1) provide a procedure for a retail pharmacy to | ||
| challenge a listed maximum allowable cost; | ||
| (2) respond to a challenge under that procedure not | ||
| later than the 15th day after the date the challenge is made; | ||
| (3) if the challenge is successful, adjust the maximum | ||
| allowable cost effective on the date the challenge is resolved and | ||
| apply the adjustment to all retail pharmacies under the contract; | ||
| (4) if the challenge is denied, provide each reason | ||
| for the denial; and | ||
| (5) report every 90 days to the system the total number | ||
| of challenges made and denied in the preceding 90-day period to the | ||
| maximum allowable cost for each medication the maximum allowable | ||
| cost of which was challenged during that period. | ||
| SECTION 6. Subchapter Y, Chapter 531, Government Code, and | ||
| Sections 1551.0671, 1575.111, 1579.058, and 1601.065, Insurance | ||
| Code, as added by this Act, apply only to a contract with a pharmacy | ||
| benefit manager entered into or renewed on or after the effective | ||
| date of this Act. | ||
| SECTION 7. This Act takes effect September 1, 2013. | ||
